| answer text |
<p>Ukraine and the UK face a shared struggle against COVID-19. We recognise the importance
of supporting Ukraine, given the additional challenges it faces as a result of Russian
aggression. Since the beginning of the pandemic, we have provided support to maximise
the effectiveness of government public communications on COVID-19, legislative assistance
to the Ministry of Health, and adapted our humanitarian aid to respond to acute needs
in the East. We are also working with civil society organisations to enhance oversight
of Covid-19 procurement, ensuring that public funds are used to maximum effect to
secure PPE, medicines, and now vaccines. UK programme support in financial year 2021/2
will be adapted to ensure that Covid-19 recovery is assisted by our work supporting
Ukraine's defence, economic development, governance reforms and humanitarian needs.</p><p>The
UK has committed £548 million to the COVAX Advanced Market Commitment (AMC) - the
international initiative to support global equitable access to vaccines, of which
the UK is one of the largest bilateral donors. Our commitment will contribute to the
supply of at least 1.3 billion doses of COVID-19 vaccines in 2021 for up to 92 low
and middle-income countries, including Ukraine, with their delivery to start shortly.</p>
|
|
